An LLC model in biotech brings specific advantages, such as streamlined deal-making, IP ownership, and capital reinvestment ...

In the second article in a series on the leadership benefits of putting employees first, Christine Miller, president and CEO ...

Part one of a two-part series that identifies current uses of AI in drug discovery and development and assesses whether AI ...

From biochemist to executive supplier to angel investor to company founder and CEO, Maria Maccecchini, Ph.D.’s ...

It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite ...

Stop spending thousands of man-hours on SDTM, ADaM and TFL generation and accelerate the delivery of clinical discoveries to patients. Transform your biostatistics deliveries with ThoughtSphere.

Over the past decade, advances in drug discovery and clinical development have led to a rise in the number of approved therapies, resulting in an increasingly competitive marketplace. These evolving ...

Then: In a 2021 “Companies To Watch” article written by Wayne Koberstein, Carisma Therapeutics CEO Steven Kelly spoke about his three-pronged mandate to fund the (then) privately held company, build a ...